NeuroSync
PrivateLast Round
Seed
Mar 11, 2019
Total Funding Raised
$4.13M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
NeuroSync is a neurotechnology company that provides a cloud-based analytics platform for assessing abnormal eye movements to aid in the diagnosis and treatment of various neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, AR/VR Hardware, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroSync Comparables
Compare NeuroSync with similar companies based on industry and business-model similarity.
NeuroSync Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2019 | ||||
| Series A Extension | Jan 3, 2018 | ||||
| Seed | Sep 7, 2017 | ||||
| Grant | Jun 13, 2017 | ||||
| Accelerator | Apr 4, 2017 |
NeuroSync Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Quadrant Management | Series A Extension |
| MassChallenge Israel | Grant, Accelerator |
| StartUp Health | Seed |
| Quartus Capital Partners | Growth Equity |
| Oceanic Partners | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Grew 32% QoQ, from 38 to 50 employees.
- Oct 11, 2025
EyeSync TBI technology has received FDA clearance.
NeuroSync Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroSync's valuation, stock price, and market status.